BLOG
March 17, 2022
The Challenges of Pharmaceutical Procurement Managing the pharmaceutical procurement process for a large health system is a complex and grueling process. Why? Because it is commonplace for these organizations to purchase from multiple manufacturers and distributors – resulting in excess of 100 accounts. With so many pharmaceutical accounts to manage, it becomes difficult to know whether health systems continue to get the correct or best price. For example, during the course of a year, a health system paid nine different prices for Astra Zeneca’s drug Symbicort ranging anywhere from $0.05 to $232. Most health systems are not equipped with the […]
December 7, 2018
The 340B Drug Discount Program is a tremendous resource for hospitals that qualify, but our experience tells us that many of them are not receiving program pricing every time they make a purchase. In this post, we’ll take a look at some common 340B pricing issues and how they occur. What makes the 340B program such a challenge to manage? The 340B program is a wide-reaching program with many moving parts, so it’s no surprise the program has a lot of room for error. For starters, obtaining 340B program approval is a complex task requiring a significant amount of time […]
June 20, 2018
The 340B Drug Discount Program offers qualified hospitals deeply discounted rates on drugs, but many aren’t using the program to its maximum benefit. A 340B pricing analysis from an experienced healthcare auditor can reveal several errors in your drug pricing and prevent you from leaving money on the table. Let’s take a look. 340B Program Challenges Just because your health system is eligible for 340B doesn’t mean it’s a turnkey process. The government and drug manufacturers adjust the pricing guidelines for 340B products every quarter, keeping back-office teams on their toes to update each item’s pricing as needed. That creates […]
